Moderna (NASDAQ: MRNA) saw its shares jump in 2021 and 2022 on the back of strong sales of its COVID-19 vaccine Spikevax. Spikevax helped prove to the world the effectiveness of messenger RNA (mRNA) technology. The company advanced three COVID-19 vaccines from phase 1 to commercial status in a year.
The rally attempt paused Wednesday as Nvidia reversed lower. Meta, Chipotle and ServiceNow led key earnings late.
Q1 2024 Viking Therapeutics Inc Earnings Call
It follows the government's decision to scrap key climate targets and its response to a review into gender services.
First Citizens BancShares' first-quarter profit beat expectations as the lender earned higher interest income and reaped the benefits of its acquisition of Silicon Valley Bank (SVB) last year. The Raleigh, North Carolina-based lender has been boosted by its buyout of SVB, which collapsed last year after a deposit flight spiraled out of control and led to the biggest banking crisis in 15 years. Since SVB's collapse, banking giants including JPMorgan Chase and HSBC have tried to beef up their businesses catering to startups and venture capital firms.
Xcel Energy posted a better-than-expected first-quarter profit on Thursday, as the electric and natural gas utility benefited from lower operating expenses due to cost-cutting initiatives and lower natural gas costs. Xcel has been embroiled in legal battles over its role in the Texas Smokehouse Creek blaze that raged in Texas, with two lawsuits claiming that it was negligent in maintaining electrical infrastructure. Its operating expenses were $2.97 billion, 15.3% lower than the prior year as the cost of natural gas sold and transported shrunk by 44% year over year.
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be
Two million people across England and Scotland are still suffering from long COVID symptoms, of whom 381,000 have had their day-to-day activities limited a lot, according to an official study published on Thursday. Britain's Office for National Statistics said 3.3% of people surveyed between Feb. 6 and March 7 reported having COVID symptoms that had lasted more than four weeks since an initial infection and were not explained by another medical condition. This was up slightly from the 2.9% of people who reported long COVID in a similar ONS survey in March 2023 which covered the whole United Kingdom, although the ONS said the two surveys' methods were not exactly comparable.
U.S. stock index futures slipped on Thursday as shares of most megacap growth stocks took a beating after dour quarterly results from Meta Platforms, ahead of more economic data in the week that could influence the Federal Reserve's monetary policy. Meta plunged 14.1% in premarket trading after the Facebook-parent forecast higher expenses and lighter-than-expected revenue.
Sabrina Carpenter went braless wearing the Mirror Palais Anemone Dress in butter featuring illusion tulle adorned with lace appliqués along the neckline and hem
DUBLIN and SHANGHAI, April 25, 2024 (GLOBE NEWSWIRE) -- PDD Holdings Inc. (“PDD Holdings” or the “Company”) (NASDAQ: PDD) today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the U.S. Securities and Exchange Commission (“SEC”) on April 25, 2024. The annual report can be accessed on the Company’s investor relations website at https://investor.pddholdings.com/ as well as the SEC’s website at https://www.sec.gov/. The Company will provide a h
AstraZeneca soundly topped analyst views while Sanofi narrowed its losses. Both stocks surged in early trade.
"Mom's going to give you a big kiss!"
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Australia Gasoline Generator Market 2024-2030" report has been added to ResearchAndMarkets.com's offering.Australia gasoline generator market size is projected to shrink at CAGR of 3.9% during 2024-2030 Approximately 72% of Australia's population is concentrated in major cities, with 26% residing in inner and outer regional areas. A mere 2% inhabit remote and very remote regions. Tropical cyclones impact the entirety of northern Australia, and the
French sales powerhouse Charades has boarded Constance Tsang’s migrant drama “Blue Sun Palace” which is set to world premiere at Cannes’ Critics’ Week. WME Independent is representing domestic rights for the movie in North America. “Blue Sun Palace” is set in the Chinese community of Queens with a vibrant cast led by award-winning Taiwanese actor …
Meta, IBM sink on earnings, American Airlines and Caterpillar report: Yahoo FinanceShares of Meta (META) are deep in the red this morning despite the company beating earnings expectations. Investors were spooked by the tech giant’s second-quarter outlook. IBM (IBM) shares are also falling this morning after reporting first-quarter revenue that missed expectations. Today we will hear from several top names including American Airlines (AAL), Caterpillar (CAT), Merck (MRK), Royal Caribbean (RCL), Microsoft (MSFT), Alphabet (GOOGL, GOOG), Intel (INTC), and Roku (ROKU). Yahoo Finance trending tickers include Chipotle (CMG), ServiceNow (NOW), and Ford (F). Key guests include:
What is behind the huge rise in shoplifting? Between 2022 and 2023, according to the British Retail Consortium, it more than doubled to 16.7 million incidents, leaving shops £1.8 billion short. The crimes affect businesses small and large, but also the people who work in them and local communities.
Q3 2024 Ethan Allen Interiors Inc Earnings Call
It's a heated election year and one hot-button issue that is driving the contentious political landscape is electric vehicles (EVs). In an ambitious effort to combat climate change, President Joe...
XOMA is entitled to a mid-single digit royalty on global OJEMDA™ sales First and only FDA-approved type II RAF inhibitor for patients with relapsed or refractory pLGG harboring a BRAF fusion or rearrangement, or BRAF V600 mutation EMERYVILLE, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today it has earned a $9 million milestone related to the U.S. Food and Drug Administration’s (FDA) approval of Day One Biopharmaceuticals’
Yahoo Finance